EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Marine-Derived Leads as Anticancer Candidates by Disrupting Hypoxic Signaling through Hypoxia-Inducible Factors Inhibition

Maria Rita Garcia iD, Paula B Andrade iD, Florence Lefranc, Nelson G M Gomes iD

Marine Drugs · 2024

DOI: 10.3390/md22040143 ↗

At a glance

Übersichtsarbeit in Marine Drugs, 2024. Written by Maria Rita Garcia and 3 co-authors. Institution: REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal. Major MEDLINE topics: Antineoplastic Agents, Aquatic Organisms, Biological Products, Hypoxia-Inducible Factor 1. Cited 11 times so far (Crossref); 337 references. The full text is freely available (open access, CC BY 4.0). Funded by: Fundação para a Ciência e Tecnologia, PT national funds.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The inadequate vascularization seen in fast-growing solid tumors gives rise to hypoxic areas, fostering specific changes in gene expression that bolster tumor cell survival and metastasis, ultimately leading to unfavorable clinical prognoses across different cancer types. Hypoxia-inducible factors (HIF-1 and HIF-2) emerge as druggable pivotal players orchestrating tumor metastasis and angiogenesis, thus positioning them as prime targets for cancer treatment. A range of HIF inhibitors, notably natural compounds originating from marine organisms, exhibit encouraging anticancer properties, underscoring their significance as promising therapeutic options. Bioprospection of the marine environment is now a well-settled approach to the discovery and development of anticancer agents that might have their medicinal chemistry developed into clinical candidates. However, despite the massive increase in the number of marine natural products classified as ‘anticancer leads,’ most of which correspond to general cytotoxic agents, and only a few have been characterized regarding their molecular targets and mechanisms of action. The current review presents a critical analysis of inhibitors of HIF-1 and HIF-2 and hypoxia-selective compounds that have been sourced from marine organisms and that might act as new chemotherapeutic candidates or serve as templates for the development of structurally similar derivatives with improved anticancer efficacy.

Subjects

MeSH terms (MEDLINE)

Antineoplastic AgentsAquatic OrganismsBiological ProductsHypoxia-Inducible Factor 1NeoplasmsAnimalsHumansBasic Helix-Loop-Helix ProteinsSignal Transduction

Author keywords

caulerpindiscorhabdindolastatin-15echinomycinepolactaenefascaplysinkalkitoxinlatrunculinplitidepsinpsammaplin

Substances

Antineoplastic AgentsBasic Helix-Loop-Helix ProteinsBiological ProductsHypoxia-Inducible Factor 1

Authors and institutions

  • REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.
  • 1H-TOXRUN-Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal.
  • UCIBIO/REQUIMTE, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
  • Department of Neurosurgery, Hôpital Universitaire de Bruxelles (H.U.B), CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.

ORCID profiles: Maria Rita Garcia, Paula B Andrade, Nelson G M Gomes

Funding

  • Fundação para a Ciência e Tecnologia
  • PT national funds

Cite

APA

Garcia, M. R., Andrade, P. B., Lefranc, F., & Gomes, N. G. M. (2024). Marine-Derived Leads as Anticancer Candidates by Disrupting Hypoxic Signaling through Hypoxia-Inducible Factors Inhibition. Marine Drugs. https://doi.org/10.3390/md22040143

Vancouver

Garcia MR, Andrade PB, Lefranc F, Gomes NGM. Marine-Derived Leads as Anticancer Candidates by Disrupting Hypoxic Signaling through Hypoxia-Inducible Factors Inhibition. Marine Drugs. 2024. doi:10.3390/md22040143

BibTeX
@article{Garcia2024,
  author = {Garcia, Maria Rita and Andrade, Paula B and Lefranc, Florence and Gomes, Nelson G M},
  title = {Marine-Derived Leads as Anticancer Candidates by Disrupting Hypoxic Signaling through Hypoxia-Inducible Factors Inhibition},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22040143}
}
Start for free →